Sensus Healthcare Beats Q3 EPS and Revenue Forecasts
Sensus Healthcare, Inc. (NASDAQ:SRTS) on November 6, 2025, announced third-quarter financial results, reporting a narrower-than-expected loss and revenue that surpassed analyst estimates.
The medical instruments company posted an earnings per share (EPS) of -$0.06. This result marked a 50% positive surprise, coming in significantly better than the anticipated loss of -$0.11 per share and the Zacks Consensus Estimate of a $0.12 loss.
Quarterly revenue totaled $6.9 million, outperforming the estimated $6.3 million and exceeding the Zacks Consensus Estimate by 48.36%. The figure was slightly above the $6.88 million from the prior quarter but fell short of the $8.84 million reported in the same quarter of the previous year. This marks the third time in the last four quarters that Sensus Healthcare has outpaced consensus revenue estimates.
The company's financial metrics show a mixed but solid balance sheet. Sensus Healthcare maintains a strong financial position with a minimal debt-to-equity ratio of about 0.011. Furthermore, the company has a robust current ratio of approximately 8.14, highlighting its ability to cover short-term liabilities.
While the company's price-to-earnings (P/E) ratio is negative at approximately -67.74 due to current losses, other valuation metrics include a price-to-sales ratio of 1.54 and an enterprise value to sales ratio of about 0.97. For more information, see the company's financial health and mission and vision.
Sensus Healthcare, Inc. (SRTS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.